Fosmanogepix Uses, Dosage, Side Effects and more
Fosmanogepix is under investigation in clinical trial NCT03604705 (An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia).
Trade Name | Fosmanogepix |
Generic | Fosmanogepix |
Fosmanogepix Other Names | Fosmanogepix |
Type | |
Formula | C22H21N4O6P |
Weight | Average: 468.406 Monoisotopic: 468.11987141 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |